Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 11, 2025 | WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs | SHANGHAI and SEOUL, South Korea , March 11, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organiza... |
| Jul 8, 2022 | WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates | SHANGHAI and SEOUL, South Korea, July 8, 2022 /PRNewswire/ -- WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) dedicated to end-to-end bioconjugates services, and AbTis, a Korean biotechnology... |
Reviews 0
FAQ about 앱티스
What has the press written about 앱티스?
Parsers VC has collected 3 articles mentioning 앱티스, among them “WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs” (Mar 11, 2025) and “WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates” (Jul 8, 2022).
Is 앱티스 still active?
앱티스 is probably closed: its latest activity on Parsers VC dates from Mar 11, 2025.